Skip to content
Friday, November 13, 2026
Megacore Technologies provides innovative IT solutions and …

Zimbabwe Declines ‘One-Sided’ US Health Aid Agreement Over Information Apprehensions

Medical funding image
The proposed American financial assistance was aimed at initiatives for treating and preventing HIV/Aids, tuberculosis, and malarial diseases.

Zimbabwe has turned down a major US healthcare agreement worth 367 million US dollars (£272m) over five years because of Washington's demand for sensitive biological samples.

The decision was revealed after a government memo dated December was disclosed, revealing that President Emmerson Mnangagwa felt the deal was "skewed".

An official spokesman later stated that the United States was seeking biological samples for research and commercial gain but refused to guarantee the resulting advantages from any future medical innovations.

"We are forced to start the difficult and regrettable task of ending our health assistance in Zimbabwe," said US ambassador to Zimbabwe Pamela Tremont publicly.

Her embassy indicated the US had furnished more than $1.9bn in health funding to Zimbabwe over the last two decades.

A medical body in Zimbabwe has urged further negotiations to reach a deal agreeable to both sides so the country's vital HIV treatment initiative can be sustained.

Wider Context

This rejection comes after a similar case in neighbouring Kenya, where a court blocked a related deal with the US following legal challenges were filed about the safety of Kenyans' medical information.

Since returning to office last year, US President Donald Trump has drastically cut foreign aid and shut down the US Agency for International Development (USAID).

USAID had overseen aid for the US government, but Trump claimed its expenditure was "inefficient" and his administration was pursuing government-to-government agreements to boost openness and accountability.

Based on statements, 16 nations in Africa have to date agreed to similar agreements, representing over $18.3bn in new funding.

Details of the Declined Agreement

This assistance for Zimbabwe would have supported "combating HIV/Aids, tuberculosis, malaria, maternal and child health, and preparing for epidemics".

"It is our view this partnership might have yielded immense benefits for the people of Zimbabwe, especially the 1.2 million presently on HIV treatment via American-funded programmes," Tremont commented.

However, government spokesperson Nick Mangwana said the proposed deal was "unfair".

"Zimbabwe was being asked to provide its genetic material and health information for a long time, without any equivalent promise of benefiting from any medical innovations – such as vaccines, diagnostics, or treatments – that might result from that shared data," he stated.

"In essence, our nation would provide the basic resources for scientific discovery without any certainty that the resulting innovations would be accessible to our people if a new disease outbreak arise."

Sovereignty and International Frameworks

Mangwana further noted that the US's withdrawal from the World Health Organization (WHO) and its push of bilateral health agreements were upending systems already established through the global health agency.

The spokesperson cited its Pandemic Benefit-Sharing scheme designed to deal with future pandemics.

"This framework is intended to ensure that when a nation contributes its information, the resulting advantages – such as medicines and cures – are distributed fairly, not monopolised exclusively by those with the funds to create them."

Zimbabwe's reservations over the US deal "must not be interpreted as hostility towards the US," he added.

"We welcome ongoing dialogue with our American counterparts on how subsequent collaboration could be structured in a way that honours the independence and dignity of each country."

Medical Community Reaction

A leading public health body said it acknowledged the government's concerns, but urged that talks should continue considering a large portion of the nation's Aids initiatives depended on international support.

"If specific concerns arise, including those relating to information security or implementation frameworks, these can often be resolved via technical clarification and negotiated safeguards," it added.

The situation emphasises the ongoing tensions between accepting vital international aid and protecting a country's data in an ever more data-driven world.

TF
Written by

Timothy Floyd

A seasoned IT consultant with over 15 years of experience in digital infrastructure and enterprise solutions, passionate about driving technological innovation.

Megacore Technologies Blog

Type to search articles.